Yale Cancer Center Study Reveals New Pathway for Brain Tumor Therapy
June 16, 2021
June 16, 2021
NEW HAVEN, Connecticut, June 16 (TNSJou) -- Yale School of Medicine issued the following news on June 15, 2021:
In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier (BBB) and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody. The study was published today online in the Journal of Clinical Investigation Insight.
"These f . . .
In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier (BBB) and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody. The study was published today online in the Journal of Clinical Investigation Insight.
"These f . . .